Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;67(6):681-687.
doi: 10.1097/MAT.0000000000001267.

Systemic Hypertension in Pediatric Veno-Venous Extracorporeal Membrane Oxygenation

Edon J Rabinowitz  1 , Kailyn McGregor  2 , Nicole R O'Connor  2 , Tara M Neumayr  1   3 , Ahmed S Said  1
Affiliations

Systemic Hypertension in Pediatric Veno-Venous Extracorporeal Membrane Oxygenation

Edon J Rabinowitz et al. ASAIO J. .

Abstract

Systemic hypertension (HTN) is a recognized complication of veno-venous (VV) extracorporeal membrane oxygenation (ECMO) in children. We sought to determine the prevalence and associated features of HTN in a retrospective cohort of children (>1 year old) supported with VV ECMO from January 2015 to July 2019 at our institution. Patient and ECMO-related characteristics were reviewed, including intensive care unit (ICU) length of stay (LOS), ECMO duration, corticosteroids and nephrotoxic medication exposure, acute kidney injury (AKI), overall fluid balance, and transfusion data. We analyzed 23 children (43% female) with a median age of 8.5 years (interquartile range [IQR] = 4-14.5). Median ICU LOS was 26 days (IQR = 15-47) with a median ECMO duration of 288 hours (IQR = 106-378) and a mortality rate of 35%. HTN was diagnosed in 87% subjects at a median of 25 ECMO hours (IQR = 9-54) of whom 55% were hypertensive >50% of their ECMO duration. AKI and fluid overload were documented in >50% of cohort. All but two subjects received at least one nephrotoxic medication, and nearly all received corticosteroids. Our data demonstrate that HTN is present in a preponderance of children supported with VV ECMO and appears within the first 3 days of cannulation. Underlying etiology is likely multifactorial.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

References

    1. Extracorporeal Life Support Organization (ELSO). ECLS Registery Report. 2020, January 25; Available at: https://www.elso.org/Registry/Statistics/InternationalSummary.aspx . Accessed April 5, 2020.
    1. Cavarocchi NC. Introduction to extracorporeal membrane oxygenation. Crit Care Clin. 33: 763–766, 2017.
    1. Blowey DL, Duda PJ, Stokes P, Hall M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens. 5: 478–483, 2011.
    1. Boedy RF, Goldberg AK, Howell CG Jr, Hulse E, Edwards EG, Kanto WP Jr. Incidence of hypertension in infants on extracorporeal membrane oxygenation. J Pediatr Surg. 25: 258–261, 1990.
    1. Heggen JA, Fortenberry JD, Tanner AJ, Reid CA, Mizzell DW, Pettignano R. Systemic hypertension associated with venovenous extracorporeal membrane oxygenation for pediatric respiratory failure. J Pediatr Surg. 39: 1626–1631, 2004.